Health Information Exchanges

  • Read more: Big Data and Pharmacovigilance, Part II
    Article

    Big Data and Pharmacovigilance, Part II

    By Dov Fox Yesterday, I wrote about Ryan Abbott‘s new article that proposes to use health information exchanges to improve the collection of data about the safety of approved drugs. Today, I want to address his recommendation that the government pay private parties to help the Food and Drug Administration conduct post-market drug surveillance. The article argues that health information…

  • Read more: Big Data and Pharmacovigilance, Part I
    Article

    Big Data and Pharmacovigilance, Part I

    By Dov Fox So much new data are created every day that 90 percent of all data worldwide has emerged in just the last two years. This information revolution has the potential, argues Bill of Health guest blogger Ryan Abbott, to transform how we develop new drugs, set clinical practices, and finance health care. His interesting new article paints an alluring “vision…